Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Proprotein convertase furin regulates osteocalcin and bone endocrine function
Omar Al Rifai, … , Nabil G. Seidah, Mathieu Ferron
Omar Al Rifai, … , Nabil G. Seidah, Mathieu Ferron
Published October 3, 2017
Citation Information: J Clin Invest. 2017;127(11):4104-4117. https://doi.org/10.1172/JCI93437.
View: Text | PDF
Research Article Bone biology Metabolism

Proprotein convertase furin regulates osteocalcin and bone endocrine function

  • Text
  • PDF
Abstract

Osteocalcin (OCN) is an osteoblast-derived hormone that increases energy expenditure, insulin sensitivity, insulin secretion, and glucose tolerance. The cDNA sequence of OCN predicts that, like many other peptide hormones, OCN is first synthesized as a prohormone (pro-OCN). The importance of pro-OCN maturation in regulating OCN and the identity of the endopeptidase responsible for pro-OCN cleavage in osteoblasts are still unknown. Here, we show that the proprotein convertase furin is responsible for pro-OCN maturation in vitro and in vivo. Using pharmacological and genetic experiments, we also determined that furin-mediated pro-OCN cleavage occurred independently of its γ-carboxylation, a posttranslational modification that is known to hamper OCN endocrine action. However, because pro-OCN is not efficiently decarboxylated and activated during bone resorption, inactivation of furin in osteoblasts in mice resulted in decreased circulating levels of undercarboxylated OCN, impaired glucose tolerance, and reduced energy expenditure. Furthermore, we show that Furin deletion in osteoblasts reduced appetite, a function not modulated by OCN, thus suggesting that osteoblasts may secrete additional hormones that regulate different aspects of energy metabolism. Accordingly, the metabolic defects of the mice lacking furin in osteoblasts became more apparent under pair-feeding conditions. These findings identify furin as an important regulator of bone endocrine function.

Authors

Omar Al Rifai, Jacqueline Chow, Julie Lacombe, Catherine Julien, Denis Faubert, Delia Susan-Resiga, Rachid Essalmani, John W.M. Creemers, Nabil G. Seidah, Mathieu Ferron

×

Figure 8

Reduced glucose tolerance in Furinosb–/– mice.

Options: View larger image (or click on image) Download as PowerPoint
Reduced glucose tolerance in Furinosb–/– mice.
(A) Fasting and fed blood...
(A) Fasting and fed blood glucose levels in 9-month-old Furinfl/fl (n = 12) and Furinosb–/– (n = 10) mice. (B) GTT results for 9-month-old Furinfl/fl (n = 21) and Furinosb–/– (n = 16) mice. Mice were fasted for 16 hours and injected i.p. with 2 g/kg glucose. (C) Fasting and fed serum insulin levels in 9-month-old Furinfl/fl (n = 12) and Furinosb–/– (n = 10) mice. (D) Pancreas insulin content in 9-month-old Furinfl/fl (n = 10) and Furinosb–/– (n = 10) mice. (E) GTT results for 4-month-old Furinfl/fl (n = 8) and Furinosb–/– (n = 7) mice after 10 weeks on a high-fat, high-sucrose diet (HFD). Mice were fasted for 6 hours and then injected i.p. with 1 g/kg glucose. Metabolic assessments were performed on male mice fed a normal chow diet (A–D) or a HFD (E). Results represent the mean ± SEM. *P < 0.05 and **P < 0.01, by 2-way ANOVA for repeated measurements with Bonferroni’s multiple comparisons test (A–C and E) or by unpaired, 2-tailed Student’s t test (D).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts